But, these findings were not proved in the studies conducted in a Norwegian population; Skjelbred et al. found that the XRCC1 399Gln allele was significantly associated with a reduction of CRC risk (OR = 0.62, 95 % CI 0.41–0.96) [16]. The gene discussed is XRCC1; the disease is colorectal carcinoma.